Clinical Trial

Evaluation of the CochSyn Device in Clinical Practice

Study acronym: Earditech 2
Completed
View on ClinicalTrials.gov →
Summary
This study investigates a new type of auditory evoked brain potentials for the quantification and classification of peripheral hearing damage (The CochSyn Test). The study will investigate the characteristics of this new auditory evoked potential marker in a cohort of people with and without self-reported hearing difficulties and test a new type of hardware that was developed to conduct the test (the CochSyn Device) in clinical practice.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-25; most recent amendment 2026-02-06.
Status change: Recruiting → Completed 2026-02-06
Status change: Not Yet Recruiting → Recruiting 2025-12-17
Trial Details
NCT Number NCT07091071
Lead Sponsor University Ghent
Conditions Hearing Loss, Sensorineural, Cochlear Hearing Loss, Cochlear Synaptopathy, DFNA9
Enrollment 65 participants
Start Date 2025-10-29
Primary Completion 2026-01-22 (estimated)
Study Completion 2026-01-22 (estimated)
Updated on ClinicalTrials.gov 2026-02-10